Aktive Positionen von Jon Filderman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACCELERON PHARMA INC. | Direktor/Vorstandsmitglied | 19.11.2021 | - |
| Unternehmenssekretär | 19.11.2021 | - |
Karriereverlauf von Jon Filderman
Ehemalige bekannte Positionen von Jon Filderman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ORGANON & CO. | Direktor/Vorstandsmitglied | - | 02.06.2021 |
Rosetta Inpharmatics LLC
 Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Corporate Officer/Principal | 08.04.2011 | - |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Corporate Secretary | 1 |
Sektoral
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ORGANON & CO. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Rosetta Inpharmatics LLC
Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Jon Filderman
- Erfahrung
